WJA
BBH icon

Williams Jones & Associates’s VanEck Biotech ETF BBH Stock Holding History

Williams Jones & Associates’s Portfolio BBH Stock Details BBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		$453K Hold
3,510
– – 0.01% 272
2019
Q1 		$451K Sell
3,510
-85
-2% -$10.7K 0.01% 282
2018
Q4 		$398K Buy
3,595
+50
+1% +$6.04K 0.01% 279
2018
Q3 		$482K Sell
3,545
-1,000
-22% -$130K 0.01% 302
2018
Q2 		$545K Sell
4,545
-800
-15% -$94.3K 0.01% 280
2018
Q1 		$643K Sell
5,345
-65
-1% -$8.16K 0.01% 260
2017
Q4 		$674K Sell
5,410
-70
-1% -$8.94K 0.02% 264
2017
Q3 		$735K Hold
5,480
– – 0.02% 252
2017
Q2 		$688K Sell
5,480
-600
-10% -$72.3K 0.02% 256
2017
Q1 		$724K Sell
6,080
-790
-11% -$92.4K 0.02% 252
2016
Q4 		$739K Sell
6,870
-455
-6% -$49.5K 0.02% 244
2016
Q3 		$844K Buy
7,325
+15
+0.2% +$1.71K 0.02% 222
2016
Q2 		$748K Sell
7,310
-60
-0.8% -$6.4K 0.02% 220
2016
Q1 		$764K Sell
7,370
-2,735
-27% -$285K 0.04% 175
2015
Q4 		$1.28M Sell
10,105
-2,250
-18% -$276K 0.06% 153
2015
Q3 		$1.41M Sell
12,355
-4,030
-25% -$533K 0.06% 160
2015
Q2 		$2.21M Buy
16,385
+275
+2% +$36.5K 0.08% 150
2015
Q1 		$2.09M Buy
16,110
+2,125
+15% +$267K 0.08% 155
2014
Q4 		$1.61M Buy
13,985
+925
+7% +$104K 0.07% 165
2014
Q3 		$1.38M Buy
13,060
+1,710
+15% +$173K 0.06% 152
2014
Q2 		$1.08M Sell
11,350
-23,850
-68% -$2.14M 0.05% 162
2014
Q1 		$3.2M Buy
35,200
+23,800
+209% +$2.31M 0.06% 154
2013
Q4 		$1.01M Sell
11,400
-3,700
-25% -$309K 0.05% 148
2013
Q3 		$1.25M Buy
+15,100
New +$1.19M 0.06% 135

Other funds holding BBH

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TIA
Traphagen Investment Advisors Oradell, New Jersey $1.4B AUM 19.32% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
MCM
Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
MJRIC
Mogy Joel R Investment Counsel Beverly Hills, California $1.75B AUM 17.81% 1-Year Est. Return
BRM
Boston Research & Management Manchester, Massachusetts $421M AUM 16.18% 1-Year Est. Return

Williams Jones & Associates's BBH Position: Q2 2019 in Review

Williams Jones & Associates held its VanEck Biotech ETF (BBH) position steady in Q2 2019 at 3,510 shares worth $453K. The position accounts for 0.01% of the portfolio, ranked #272.

Williams Jones & Associates first reported a position in BBH in Q3 2013 and has held it in 24 quarters since. The position peaked at $3.2M in Q1 2014. 84 funds tracked by Wall St. Rank hold BBH as of Q2 2019.

  • Williams Jones & Associates held 3,510 shares of VanEck Biotech ETF worth $453K as of Q2 2019.
  • Williams Jones & Associates left its VanEck Biotech ETF share count unchanged in Q2 2019.
  • VanEck Biotech ETF made up 0.01% of Williams Jones & Associates's portfolio in Q2 2019, its #272 holding.
  • Williams Jones & Associates first reported a position in VanEck Biotech ETF in Q3 2013 and has held it in 24 quarters since.
  • Williams Jones & Associates's VanEck Biotech ETF position peaked at $3.2M in Q1 2014.
  • 84 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q2 2019.

Based on Williams Jones & Associates's 13F filing for Q2 2019, filed 14 Aug 2019.